A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice
Clinical trial NCT00855738 · COMPLETED
Trial details
- NCT number
- NCT00855738
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2009-06-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.